Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Lung Neoplasms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

All Drugs and Chemicals

Central Nervous System Stimulants

Nicotine

Nicotinic Agonists

Cholinergic Agents

Neurotransmitter Agents

Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges).

Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges), 6 telephone counseling sessions over 6 months, and access to a web based video.

Participants will receive nicotine patch and lozenges. The regimen will be based on the participant's self-reported smoking rate. At the time of enrollment, a research staff member will determine the proper dose. Participants who smoke \>10 cigarettes/day will receive 8 weeks of 21 mg. patches, 2 weeks of 14 mg. patches, 2 weeks of 7 mg. patches, and 12 weeks of 2 mg. lozenges. Those who smoke \<10 cigarettes/day will receive 8 weeks of 14 mg. patches, 4 weeks of 7 mg patches, and 12 weeks of 2 mg. lozenges

Nicotine patch and lozenges

Participants will be offered 6 Motivation and Problem Solving (MAPS)-based counseling sessions by phone over a 6-month period.

Telephone counseling sessions

Participants will be given web-based access to the relapse prevention video "Surviving Smokefree".

Access to a web-based video

Participants will receive an offer of enrollment to the Florida Tobacco Quitline which enables participant to speak with a Quit Coach who will assess nicotine addiction and help create a quit plan.

Florida Tobacco Quitline

Vani N Simmons, PhD

Jennifer I Vidrine, PhD

The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.

Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free

Motivating Smoking Cessation and Relapse Prevention Among Lung Cancer Patients: Helping and Empowering pAtients for Living a Life Smoke-free (Project HEALS)

Percentage of participants who meet inclusion criteria

Percentage of participants who agree to participate in the study

Percentage of participants completing baseline assessment

Percentage of participants completing the 3 month follow-up assessments

Percentage of participants completing the 6 month follow-up assessments

Mean scores of the Client Satisfaction Questionnaire (SCQ-8) will be used for this measure. The CSQ-8 comprises 8 items for the assessment of treatment satisfaction using a scale from 8 to 32, with higher scores indicating greater satisfaction.

Percentage of MAPS calls completed for UC+MAPS+RP participants

Percentage of UC+MAPS+RP participants who viewed the web based video

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free	NCT05362318	Smoking Tobacco Use Lung Cancer	Nicotine patch ... Telephone couns... Access to a web... Florida Tobacco...	18 Years -	H. Lee Moffitt Cancer Center and Research Institute
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free	NCT05362318	Smoking Tobacco Use Lung Cancer	Nicotine patch ... Telephone couns... Access to a web... Florida Tobacco...	18 Years -	H. Lee Moffitt Cancer Center and Research Institute

Spots Global Cancer Trial Database for nicotine patch and lozenges